Gov. Brown Signs “Co-Pay Cap” Legislation Keeping Prescription Drugs Affordable

SB 1021 has been signed into law. Project Inform worked hard with our partners including Health Access on this bill which now explicitly protects PrEP as well. We continue to work with the Department of Managed Health Care on the monitoring of the legislation particularly in…Read More

Urge Your Senators to Vote NO on Kavanaugh to the Supreme Court

Reprinted from The National Health Law Program’s Facebook page. The National Health Law Program advocates for the rights of low-income and under-served people to access quality health care. Urge Your Senators to Vote No on Kavanaugh Based on Brett Kavanaugh’s record, National Health Law Program and…Read More

Seeking your help to end the HIV and hepatitis C epidemics and significantly reduce the incidence of STDs in California!

Project Inform is partnering with HIV, hepatitis and STD organizations from across the state to call on the next Governor of California to develop and implement a statewide plan to end the HIV and hepatitis C epidemics and to significantly reduce the incidence of STDs. We…Read More

Project Inform announces new Development Officer position open

Project Inform has announced the availability of a new position with the organization,  Development Officer. The position is responsible for the strategic vision, planning and implementation of Project Inform’s individual fundraising efforts, including individual donor engagement and fundraising events. The Development Officer is also responsible for…Read More

IAS2018: PrEP use linked to fewer new HIV infections in US states

Published by and re-posted from As pre-exposure prophylaxis (PrEP) use continues to grow, epidemiological evidence is starting to show an association between increases in PrEP uptake and declines in new infections. A new analysis presented this week at the 22nd International AIDS Conference (AIDS 2018)…Read More

IAS2018: PrEP does not lower feminising hormone level in transgender women

Published by and re-posted from Tenofovir levels fell slightly, but implications for HIV prevention are unclear Using Truvada (tenofovir DF/emtricitabine) for HIV prevention does not lower levels of feminising hormones, offering reassurance for transgender women who are concerned about drug interactions, according to a presentation…Read More

IAS2018: Zero transmissions mean zero risk – PARTNER 2 study results announced

Reported by and re-posted from We’re as confident now that undetectable gay men pose no risk of HIV transmission as we already were for heterosexuals, researchers say The chance of any HIV-positive person with an undetectable viral load transmitting the virus to a sexual partner…Read More